Cargando…
Bee Venom Alleviates Atopic Dermatitis Symptoms through the Upregulation of Decay-Accelerating Factor (DAF/CD55)
Bee venom (BV)—a complex mixture of peptides and toxic proteins including phospholipase A2 and melittin—promotes blood clotting. In this study, we investigated the anti-atopic properties of BV and the mechanism associated with its regulation of the complement system. BV treatment upregulated the mRN...
Autores principales: | Kim, Yenny, Lee, Youn-Woo, Kim, Hangeun, Chung, Dae Kyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562486/ https://www.ncbi.nlm.nih.gov/pubmed/31027358 http://dx.doi.org/10.3390/toxins11050239 |
Ejemplares similares
-
Therapeutic effects of bee venom on experimental atopic dermatitis
por: Gu, Hyemin, et al.
Publicado: (2018) -
Bee venom acupuncture alleviates trimellitic anhydride-induced atopic dermatitis-like skin lesions in mice
por: Sur, Bongjun, et al.
Publicado: (2016) -
Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro
por: An, Hyun‐Jin, et al.
Publicado: (2018) -
Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
por: Koretz, K., et al.
Publicado: (1992) -
Complement Inactivation Strategy of Staphylococcus aureus Using Decay-Accelerating Factor and the Response of Infected HaCaT Cells
por: Jang, Kyoung Ok, et al.
Publicado: (2021)